American Society of Hematology

Fig. 3.

$Fig. 3. Cumulative incidences of relapse in CR1, CR2/3, and refractory poor-risk ALL following unrelated donor BMT.$

Cumulative incidences of relapse in CR1, CR2/3, and refractory poor-risk ALL following unrelated donor BMT.